IDOV-Safe
/ ViroMissile
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 24, 2025
LY001-I001: A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
(clinicaltrials.gov)
- P1 | N=89 | Recruiting | Sponsor: Peking University | N=60 ➔ 89
Enrollment change • Cholangiocarcinoma • Colorectal Cancer • Gastrointestinal Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1